Revenue
$141.2m
-2.0% ↓ vs $144.2m
Net operating income contracted despite 4.2% receivables growth, pointing to material net interest margin compression ahead of Challenger integration.
Revenue context before the current result.
Operating profit margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY24 vs HY23
Revenue
$141.2m
-2.0% ↓ vs $144.2m
Net profit after tax
$37.6m
-22.8% ↓ vs $48.7m
Net cash inflow from operating activities
−$8.8m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Interim dividend per share
4.0c
-27.3% ↓ vs 5.5c
Profit before tax
$52.6m
-23.8% ↓ vs $69m
Cash and cash equivalents
$286.9m
-25.5% ↓ vs $385.3m
Total assets
$7.9b
+6.6% ↑ vs $7.4b
What changed
Profit before tax dropped 23.8% to NZ$52.6m and NPAT fell 22.8% to NZ$37.6m, both at the lower edge of the supplied historical range.
The balance sheet still expanded: total assets rose 6.6% to NZ$7.9b and gross borrowings rose 8.0% to NZ$6.8b, with management citing receivables growth of 4.2%. The interim dividend was cut 27.3% to 4.0 cps from 5.5 cps. An acquisition overlay (Challenger Bank, Australia) is in play and shapes the forward read.
What matters
Receivables growth of 4.2% would normally drive net operating income higher, yet NOI fell 2.0%. The implication is that net interest margin contracted enough to offset volume growth — a structural pressure rather than a one-off, and the most important read in this release.
Profitability ratios held even as absolute earnings fell. PBT margin of 37.2% and NPAT margin of 26.6% both sit within the supplied historical range (4-period means of 35.1% and 25.2% respectively). That means the earnings drop is being driven by the top line and balance-sheet costs, not by an operating-cost blow-out, so the recovery path depends on funding spreads stabilising.
ROE has weakened to 3.7% from 4.8%, near the bottom of the historical range. With equity essentially flat (+0.5%) and assets up 6.6%, the group is running a larger book on similar capital while earning less from it. The dividend cut and the pending Challenger acquisition together signal that capital is being prioritised for growth, not distribution.
Expectations
Seasonality context is limited but not strongly skewed: in FY23 the first half delivered 49.7% of full-year revenue and 50.8% of NPAT, so HY24 is broadly on a like-for-like footing rather than benefiting from a structurally weaker comparable. Annualising the current half implies revenue of roughly NZ$282m, modestly below FY23's NZ$289.8m.
The Challenger acquisition overlay means HY24 cannot be treated as a clean run-rate for FY24. Integration costs, day-one accounting, and any uplift from the acquired Australian deposit base will reshape the second half. The release does not quantify expected accretion, so any forward judgement here is provisional.
Quality of result
Profit from continuing operations equals reported NPAT (NZ$37.6m), and the effective tax rate of 28.5% is within the historical range (4-period mean 29.2%) — so neither tax nor discontinued items are masking the operating decline. Management discloses an underlying NPAT of NZ$52.7m versus reported NZ$37.6m; a NZ$15.1m gap that is not explained in the supplied excerpts, which weakens the durability read until the bridge is examined.
For a lender, operating cash flow swings with movements in deposits and receivables and is not a clean conversion proxy. Even so, capex of NZ$16.7m more than doubled from NZ$7.7m, lifting capex intensity to 11.8% of revenue from 5.4%, and pre-lease free cash flow turned negative at NZ$-25.5m — at the lower edge of Annolyse's historical baseline (4-period mean NZ$158.9m). The 4.0 cps interim is funded from balance-sheet capacity, not current free cash, with payout versus pre-lease FCF at -111.2%.
Unresolved
This briefing cannot assess the underlying NIM trajectory, the Challenger transaction economics, or the sustainability of receivables growth without disclosure of segment-level margins and the underlying-to-reported NPAT bridge.
Chat
Ask follow-up questions about Heartland Group Holdings's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Heartland 1H24 - HGH Financial Statements
HY24 / financial reportHeartland 1H24 - Investor Presentation
HY24 / results presentationHeartland 1H24 - Results Announcement
HY24 / results releaseHeartland 1H24 - Results Announcement Template
HY24 / results announcementHeartland - 1H2023 HGH Financial Statements
HY23 / financial reportHeartland - 1H2023 Results Announcement Template
HY23 / results announcementHeartland - 1H2023 Results Release
HY23 / results releaseHeartland FY23 - HGH Financial Statements
FY23 / financial reportHeartland FY23 - NZX Results Announcement
FY23 / results announcementHeartland FY23 - NZX Results Announcement
FY23 / results releaseRelated insights
Cross-company views selected from the metrics in this briefing.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 75.5%.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 1.0pp.
Revenue growth context
Revenue growth was -2.0% for this reporting period.
ROE and capital efficiency
ROE was 3.7%, -1.1pp versus the prior comparable period.
Get the next Heartland Group Holdings briefing and related NZX reporting-season updates by email.